Temporal Investigation of Multimodal Elements
TIME
An Observational, Longitudinal Study to Characterize the Dynamic Structure of Molecular and Digital Health Data in Healthy Older Adults
2 other identifiers
observational
120
1 country
1
Brief Summary
The TIME Study is a research project aiming to understand the body's natural rhythms. The goal is to see how daily and weekly changes in our bodies-from what's happening at a molecular level to data from wearable devices-are connected. What is the study about? This study is trying to create a detailed map of how a person's body changes over time. By looking at information from blood, urine, and other samples, as well as data from smartwatches and other devices, researchers want to learn how our bodies' natural cycles work in healthy older adults. The long-term goal is to use this knowledge to help develop more personalized healthcare in the future. Who can participate? The study is looking for healthy adults, age 55 or older, who have a smartphone and are able to travel to the Buck Institute in Novato, California, for study visits. Participants will be asked to: Attend weekly visits over 11 weeks to provide blood and other samples. Wear health-tracking devices like a smart ring and watch. Use a smartphone app to answer questions about their daily routines. Complete two "challenge" tests, including drinking a glucose solution and exercising on a stationary bicycle. Return for follow-up visits after 6 and 12 months. Are there any risks or benefits? Benefits: There are no direct health benefits for participants. However, the information gained will help scientists create better diagnostic tools and treatments for future generations. Risks: The main risks are minor discomfort from things like blood draws or skin irritation from the wearable devices. All personal information and data are kept private and secure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2025
CompletedFirst Submitted
Initial submission to the registry
July 30, 2025
CompletedFirst Posted
Study publicly available on registry
August 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
August 15, 2025
August 1, 2025
2 years
July 30, 2025
August 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Generation of a longitudinal multi-omic and digital health dataset characterizing biorhythms in older adults
Establish a publicly shareable reference dataset integrating blood-based proteomic, metabolomic, and lipidomic profiles with continuous digital health data and microbiome samples from healthy older adults over time, capturing daily, weekly, and perturbation-induced physiological dynamics.
12 months
Secondary Outcomes (1)
Characterization of associations between molecular biomarkers and digital health data across time
12 months
Eligibility Criteria
The study population consists of healthy older adults aged 55 years or older.
You may qualify if:
- Healthy adults aged 55 years or older.
- Own a smartphone capable of running study-specific apps.
- Willing and able to attend in-person visits at the Buck Institute in Novato, CA.
- Reside in the Pacific or Mountain Time Zones.
- Able to speak, read, and write English.
- Willing to wear study devices continuously and allow researchers access to all data.
- Able to provide informed consent.
You may not qualify if:
- Hospitalization within the last 3 months.
- Needing assistance with daily living activities.
- Working night or irregular shifts.
- Certain musculoskeletal, pulmonary, or cardiovascular conditions.
- Uncontrolled high blood pressure (BP \> 180/100 mmHg).
- Bleeding disorders, anemia requiring treatment, or recent blood donation.
- Poor vein access.
- Unstable health conditions.
- Chronic antibiotic use.
- Certain psychiatric disorders.
- Use of excluded medications, supplements, or products, including certain antibiotics or frequent sleep aids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Buck Institute for Research on Aginglead
- Phenome Healthcollaborator
Study Sites (1)
Buck Institute
Novato, California, 94945, United States
Study Officials
- PRINCIPAL INVESTIGATOR
James Yurkovich, PhD
Phenome Health, The Buck Institute for Research on Aging
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2025
First Posted
August 6, 2025
Study Start
June 15, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
August 15, 2025
Record last verified: 2025-08